Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1162. Iezzoni JC, Fechner RE, Wong LS,
Rosai J (1995). Aggressive angiomyxoma
in males. A report of four cases. Am J Clin
Pathol 104: 391-396.
1163. Iezzoni JC, Kap-Herr C, Golden WL,
Gaffey MJ (1997). Gonadoblastomas in
45,X/46,XY mosaicism: analysis of Y chromosome
distribution by fluorescence in
situ hybridization. Am J Clin Pathol 108:
197-201.
1164. Igawa M, Urakami S, Shirakawa H,
Shiina H, Ishibe T, Usui T, Moriyama H
(1995). A mapping of histology and cell proliferation
in human bladder cancer: an
immunohistochemical study. Hiroshima J
Med Sci 44: 93-97.
1165. Igel TC, Engen DE, Banks PM,
Keeney GL (1991). Renal plasmacytoma:
Mayo Clinic experience and review of the
literature. Urology 37: 385-389.
1166. Iizumi T, Shinohara S, Amemiya H,
Tomomasa H, Yazaki T, Umeda T, Tanaka
F, Imamura T (1995). Plasmacytoma of the
testis. Urol Int 55: 218-221.
1167. Ikeda I, Miura T, Kondo I, Kameda Y
(1996). Neurilemmoma of the kidney. Br J
Urol 78: 469-470.
1168. Ikeda I, Miura T, Kondo I, Kimura A
(1996). Metastatic choriocarcinoma of the
kidney discovered by refractory hematuria.
Hinyokika Kiyo 42: 447-449.
1169. Ingles SA, Coetzee GA, Ross RK,
Henderson BE, Kolonel LN, Crocitto L,
Wang W, Haile RW (1998). Association of
prostate cancer with vitamin D receptor
haplotypes in African-Americans. Cancer
Res 58: 1620-1623.
1170. Ingles SA, Ross RK, Yu MC, Irvine RA,
La Pera G, Haile RW, Coetzee GA (1997).
Association of prostate cancer risk with
genetic polymorphisms in vitamin D receptor
and androgen receptor. J Natl Cancer
Inst 89: 166-170.
1171. Insabato L, de Rosa G, Terracciano
LM, Fazioli F, di Santo F, Rosai J (2002).
Primary monotypic epithelioid angiomyolipoma
of bone. Histopathology 40: 286-
290.
1172. Ioachim E, Charchanti A,
Stavropoulos NE, Skopelitou A,
Athanassiou ED, Agnantis NJ (2000).
Immunohistochemical expression of
retinoblastoma gene product (Rb), p53
protein, MDM2, c-erbB-2, HLA-DR and
proliferation indices in human urinary
bladder carcinoma. Histol Histopathol 15:
721-727.
1173. Isa SS, Almaraz R, Magovern J
(1984). Leiomyosarcoma of the penis. Case
report and review of the literature. Cancer
54: 939-942.
1174. Isaacson PG, Norton AJ (1994).
Extranodal Lymphomas. Churchill
Livingstone: Edinburgh.
1175. Ishida Y, Kato K, Kigasawa H, Ohama
Y, Ijiri R, Tanaka Y (2000). Synchronous
occurrence of pleuropulmonary blastoma
and cystic nephroma: possible genetic link
in cystic lesions of the lung and the kidney.
Med Pediatr Oncol 35: 85-87.
1176. Ishigooka M, Yaguchi H, Tomaru M,
Sasagawa I, Nakada T, Mitobe K (1994).
Mixed prostatic carcinoma containing
malignant squamous element. Reports of
two cases. Scand J Urol Nephrol 28: 425-
427.
1177. Ishikawa J, Xu HJ, Hu SX, Yandell
DW, Maeda S, Kamidono S, Benedict WF,
Takahashi R (1991). Inactivation of the
retinoblastoma gene in human bladder and
renal cell carcinomas. Cancer Res 51:
5736-5743.
1178. Ishimaru H, Kageyama Y, Hayashi T,
Nemoto T, Eishi Y, Kihara K (2002).
Expression of matrix metalloproteinase-9
and bombesin/gastrin-releasing peptide in
human prostate cancers and their lymph
node metastases. Acta Oncol 41: 289-296.
1179. Ishiwata S, Takahashi S, Homma Y,
Tanaka Y, Kameyama S, Hosaka Y,
Kitamura T (2001). Noninvasive detection
and prediction of bladder cancer by fluorescence
in situ hybridization analysis of
exfoliated urothelial cells in voided urine.
Urology 57: 811-815.
1180. Isobe H, Takashima H, Higashi N,
Murakami Y, Fujita K, Hanazawa K, Fujime
M, Matsumoto T (2000). Primary carcinoid
tumor in a horseshoe kidney. Int J Urol 7:
184-188.
1181. Israeli RS, Wise GJ, Bansal S, Gerard
PS, Castella A (1995). Bilateral renal oncocytomatosis
in a patient with renal failure.
Urology 46: 873-875.
1182. Issa MM, Yagol R, Tsang D (1993).
Intrascrotal neurofibromas. Urology 41:
350-352.
1183. Isshiki S, Akakura K, Komiya A,
Suzuki H, Kamiya N, Ito H (2002). Chromogranin
a concentration as a serum marker
to predict prognosis after endocrine therapy
for prostate cancer. J Urol 167: 512-
515.
1184. Ito J, Shinohara N, Koyanagi T,
Hanioka K (1998). Ossifying renal tumor of
infancy: the first Japanese case with longterm
follow-up. Pathol Int 48: 151-159.
1185. Ito T, Yamamoto S, Ohno Y, Namiki K,
Aizawa T, Akiyama A, Tachibana M (2001).
Up-regulation of neuroendocrine differentiation
in prostate cancer after androgen
deprivation therapy, degree and androgen
independence. Oncol Rep 8: 1221-1224.
1186. Ivanov SV, Kuzmin I, Wei MH, Pack S,
Geil L, Johnson BE, Stanbridge EJ, Lerman
MI (1998). Down-regulation of transmembrane
carbonic anhydrases in renal cell
carcinoma cell lines by wild-type von
Hippel-Lindau transgenes. Proc Natl Acad
Sci USA 95: 12596-12601.
1187. Iversen T, Tretli S, Johansen A, Holte
T (1997). Squamous cell carcinoma of the
penis and of the cervix, vulva and vagina in
spouses: is there any relationship? An epidemiological
study from Norway, 1960-92.
Br J Cancer 76: 658-660.
1188. Iwai K, Yamanaka K, Kamura T,
Minato N, Conaway RC, Conaway JW,
Klausner RD, Pause A (1999). Identification
of the von Hippel-Lindau tumor-suppressor
protein as part of an active E3 ubiquitin ligase
complex. Proc Natl Acad Sci USA 96:
12436-12441.
1189. Iwasaki H, Ishiguro M, Ohjimi Y,
Ikegami H, Takeuchi T, Kikuchi M, Kaneko
Y, Ariyoshi A (1999). Synovial sarcoma of
the prostate with t(X;18)(p11.2;q11.2). Am J
Surg Pathol 23: 220-226.
1190. Iwata H, Yokoyama M, Morita M,
Bekku T, Ochi K, Takeuchi M (1982).
Inverted papilloma of urinary bladder.
Scanning and transmission electron
microscopic observation. Urology 19: 322-
324.
1191. Izquierdo MA, van der Valk P, van
Ark-Otte J, Rubio G, Germa-Lluch JR, Ueda
R, Scheper RJ, Takahashi T, Giaccone G
(1995). Differential expression of the c-kit
proto-oncogene in germ cell tumours. J
Pathol 177: 253-258.
1192. Jacobo E, Loening S, Schmidt JD,
Culp DA (1977). Primary adenocarcinoma
of the bladder: a retrospective study of 20
patients. J Urol 117: 54-56.
1193. Jacobs SC, Berg SI, Lawson RK
(1980). Synchronous bilateral renal cell
carcinoma: total surgical excision. Cancer
46: 2341-2345.
1194. Jacobsen GK (1993). Malignant
Sertoli cell tumors of the testis. J Urol
Pathol 1: 233-255.
1195. Jacobsen GK, Barlebo H, Olsen J
(1984). Testicular germ cell tumors in
Denmark 1976-1980: pathology of 1058 consecutive
cases. Acta Radiol Oncol 23: 293-
347.
1196. Jacobsen GK, Jacobsen M (1983).
Alpha-fetoprotein (AFP) and human chorionic
gonadotropin (HCG) in testicular germ
cell tumours. A prospective immunohistochemical
study. Acta Pathol Microbiol
Immunol Scand [A] 91: 165-176.
1197. Jacobsen GK, Jacobsen M (1983).
Possible liver cell differentiation in testicular
germ cell tumours. Histopathology 7:
537-548.
1198. Jacobsen GK, Jacobsen M, Clausen
PP (1981). Distribution of tumor-associated
antigens in the various histologic components
of germ cell tumors of the testis. Am
J Surg Pathol 5: 257-266.
1199. Jacobsen GK, Norgaard-Pedersen B
(1984). Placental alkaline phosphatase in
testicular germ cell tumours and in carcinoma-in-situ
of the testis. An immunohistochemical
study. Acta Pathol Microbiol
Immunol Scand [A] 92: 323-329.
1200. Jacobsen GK, Rorth M, Osterlind K,
von der Maase H, Jacobsen A, Madsen
EL, Pedersen M, Schultz H (1990). Histopathological
features in stage I nonseminomatous
testicular germ cell
tumours correlated to relapse. Danish
Testicular Cancer Study Group. APMIS
98: 377-382.
1201. Jacobsen GK, Talerman A (1989).
Atlas of Germ Cell Tumours. Munksgaard:
Copenhagen.
1202. Jacobsen GK, von der Maase H,
Specht L (1995). Histopathological features
of stage I seminoma treated with orchidectomy
only. J Urol Pathol 3: 85-94.
1203. Jacobsen R, Bostofte E, Engholm G,
Hansen J, Olsen JH, Skakkebaek NE,
Moller H (2000). Risk of testicular cancer in
men with abnormal semen characteristics:
cohort study. BMJ 321: 789-792.
1204. Jaeger N, Weissbach L, Bussar-
Maatz R (1994). Size and status of metastases
after inductive chemotherapy of
germ-cell tumors. Indication for salvage
operation. World J Urol 12: 196-199.
1205. Jahn H, Nissen HM (1991).
Haemangioma of the urinary tract: review
of the literature. Br J Urol 68: 113-117.
1206. Jahnson S, Karlsson MG (2000).
Tumor mapping of regional immunostaining
for p21, p53, and mdm2 in locally
advanced bladder carcinoma. Cancer 89:
619-629.
1207. Jahnson S, Risberg B, Karlsson MG,
Westman G, Bergstrom R, Pedersen J
(1995). p53 and Rb immunostaining in locally
advanced bladder cancer: relation to
prognostic variables and predictive value
for the local response to radical radiotherapy.
Eur Urol 28: 135-142.
1208. Jamieson NV, Bullock KN, Barker TH
(1986). Adenosquamous carcinoma of the
penis associated with balanitis xerotica
obliterans. Br J Urol 58: 730-731.
1209. Jarvinen TA, Tanner M, Barlund M,
Borg A, Isola J (1999). Characterization of
topoisomerase II alpha gene amplification
and deletion in breast cancer. Genes
Chromosomes Cancer 26: 142-150.
1210. Jarvinen TA, Tanner M, Rantanen V,
Barlund M, Borg A, Grenman S, Isola J
(2000). Amplification and deletion of topoisomerase
IIalpha associate with ErbB-2
amplification and affect sensitivity to topoisomerase
II inhibitor doxorubicin in breast
cancer. Am J Pathol 156: 839-847.
1211. Javadpour N (1986). Misconceptions
and source of errors in interpretation of
cellular and serum markers in testicular
cancer. J Urol 135: 879.
1212. Jeffers M, Fiscella M, Webb CP,
Anver M, Koochekpour S, Vande Woude
GF (1998). The mutationally activated Met
receptor mediates motility and metastasis.
Proc Natl Acad Sci USA 95: 14417-14422.
1213. Jeffers M, Schmidt L, Nakaigawa N,
Webb CP, Weirich G, Kishida T, Zbar B,
Vande Woude GF (1997). Activating mutations
for the met tyrosine kinase receptor in
human cancer. Proc Natl Acad Sci USA 94:
11445-11450.
1214. Jenkins RB, Qian J, Lieber MM,
Bostwick DG (1997). Detection of c-myc
oncogene amplification and chromosomal
anomalies in metastatic prostatic carcinoma
by fluorescence in situ hybridization.
Cancer Res 57: 524-531.
1215. Jensen OM, Knudsen JB, McLaughlin
JK, Sorensen BL (1988). The Copenhagen
case-control study of renal pelvis and
ureter cancer: role of smoking and occupational
exposures. Int J Cancer 41: 557-561.
1216. Jhavar S, Agarwal JP, Naresh KN,
Shrivastava SK, Borges AM, Dinshaw KA
(2001). Primary extranodal mucosa associated
lymphoid tissue (MALT) lymphoma of
the prostate. Leuk Lymphoma 41: 445-449.
1217. Ji X, Li W (1994). Primary carcinoid of
the renal pelvis. J Environ Pathol Toxicol
Oncol 13: 269-271.
1218. Jiang F, Desper R, Papadimitriou CH,
Schaffer AA, Kallioniemi OP, Richter J,
Schraml P, Sauter G, Mihatsch MJ, Moch
H (2000). Construction of evolutionary tree
models for renal cell carcinoma from comparative
genomic hybridization data.
Cancer Res 60: 6503-6509.
1219. Jiang F, Richter J, Schraml P,
Bubendorf L, Gasser T, Sauter G, Mihatsch
MJ, Moch H (1998). Chromosomal imbalances
in papillary renal cell carcinoma:
genetic differences between histological
subtypes. Am J Pathol 153: 1467-1473.
1220. Jiang Z, Woda BA, Rock KL, Xu Y,
Savas L, Khan A, Pihan G, Cai F, Babcook
JS, Rathanaswami P, Reed SG, Xu J,
Fanger GR (2001). P504S: a new molecular
marker for the detection of prostate carcinoma.
Am J Surg Pathol 25: 1397-1404.
1221. Jiang Z, Wu CL, Woda BA, Dresser K,
Xu J, Fanger GR, Yang XJ (2002).
P504S/alpha-methylacyl-CoA racemase: a
useful marker for diagnosis of small foci of
prostatic carcinoma on needle biopsy. Am
J Surg Pathol 26: 1169-1174.
1222. Jiborn T, Bjartell A, Abrahamsson PA
(1998). Neuroendocrine differentiation in
prostatic carcinoma during hormonal treatment.
Urology 51: 585-589.
1223. Jimenez-Quintero LP, Ro JY, Zavala-
Pompa A, Amin MB, Tetu B, Ordonez NG,
Ayala AG (1993). Granulosa cell tumor of
the adult testis: a clinicopathologic study of
seven cases and a review of the literature.
Hum Pathol 24: 1120-1125.
1224. Jimenez RE, Eble JN, Reuter VE,
Epstein JI, Folpe AL, Peralta-Venturina M,
Tamboli P, Ansell ID, Grignon DJ, Young
RH, Amin MB (2001). Concurrent angiomyolipoma
and renal cell neoplasia: a study of
36 cases. Mod Pathol 14: 157-163.
324 References